Table 1 The frequency distribution of patients by CKD stages, gender, age and comorbidities
From: Salivary creatinine as a diagnostic tool for evaluating patients with chronic kidney disease
Gender | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Stage 5 | Total |
|---|---|---|---|---|---|---|
Male | 16 | 17 | 23 | 19 | 14 | 89 (38.7%) |
Female | 34 | 33 | 27 | 21 | 26 | 141 (61.3%) |
All | 50 | 50 | 50 | 40 | 40 | 230 (100%) |
Age range Median age Interquartile range (Q1-Q3) | 18–54 31.0 (21.25-39.75) | 19–73 38.5 (31.25-49.50) | 19–73 38.0 (31.0-51.0) | 20–82 40.5 (33.75-47.5) | 21–66 47.5 (40.5-54.25) | |
Patients with co-morbidities | 34 | 47 | 44 | 39 | 40 | 204 |
Hypertension and diabetes (2) | Hypertension and diabetes (7) | Hypertension and diabetes (5) | Hypertension and diabetes (4) | Hypertension and diabetes (10) | ||
Hypertension (28) | Hypertension (36) | Hypertension (34) | Hypertension (32) | Hypertension (29) | ||
Diabetes (1) | Diabetes (2) | Diabetes (2) | Diabetes (1) | Diabetes (0) | ||
Other (3) | Other (2) | Other (3) | Other (2) | Other (1) |